Company intelligence / Profile preview

Microbiome Insights

Richmond, British Columbia, Canada

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Microbiome Insights operates a College of American Pathologists (CAP)–accredited laboratory providing commercial microbiome sequencing, bioinformatics, and a microbiome-based chronic disease management testing platform that includes an IBD-focused test marketed to clinicians and to pharma as a biomarker tool for clinical development.[2][3][4][5]

Therapeutic areas: Gastroenterology
Modalities: Non-pharmacological therapy
Industry: Molecular Diagnostics

Partnerships

Health Canada (Innovative Solutions Canada contract for microbial biotechnology product testing platform)

Beyond the preview

Go deeper on Microbiome Insights.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome Insights.

Explore the full profile